search
Back to results

Optimal Multimodal Analgesia in Laparoscopic Cholecystectomy

Primary Purpose

Cholecystolithiasis

Status
Unknown status
Phase
Phase 4
Locations
Denmark
Study Type
Interventional
Intervention
Gabapentin
S-ketamine
Lidocaine
Droperidol
Sponsored by
Hvidovre University Hospital
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cholecystolithiasis

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Elective laparoscopic cholecystectomy Age above 18 years Written informed consent ASA class I-III Exclusion Criteria: Planned abdominal cholecystectomy Intraoperative conversion of laparoscopic to laparotomic cholecystectomy Allergy to part of the treatment regimens Previous reactions to opioids (nausea, cognition)

Sites / Locations

  • Dept of Anaesthesia, Hvidovre Hospital

Outcomes

Primary Outcome Measures

1. postoperative abilities over time in PACU
2. discharge time from PACU according to fixed criteria
3. consumption of analgesics and antiemetics in the PACU

Secondary Outcome Measures

1. Degree of nursing requirements in the PACU
2. General tolerability of the regimens

Full Information

First Posted
September 14, 2005
Last Updated
September 14, 2005
Sponsor
Hvidovre University Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT00209885
Brief Title
Optimal Multimodal Analgesia in Laparoscopic Cholecystectomy
Study Type
Interventional

2. Study Status

Record Verification Date
September 2005
Overall Recruitment Status
Unknown status
Study Start Date
October 2005 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
undefined (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
Hvidovre University Hospital

4. Oversight

5. Study Description

Brief Summary
To test the current standard of care (SOC) treatment for laparoscopic cholecystectomy with a group receiving SOC + additional perioperative analgesics in terms of postoperative abilities, PONV, pain and discharge time from the PACU
Detailed Description
Aim of the study: to compare postoperative complaints (PONV, pain, etc) and PACU discharge time between two groups: A: standard of care (SOC)receiving intraoperative dexamethasone, ondansetron, ketorolac, and general anaesthesia with propofol, remifentanil and cisatracurium B: SOC + preoperative gabapentin, intraoperative lidocain infusion, s-ketamin and droperidol. Primary endpoints: postoperative abilities over time discharge time from PACU according to fixed criteria consumption of analgesics and antiemetics in the PACU Secondary endpoints: degree of nursing requirements at the PACU General tolerability of the regimes

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cholecystolithiasis

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
Double
Allocation
Randomized
Enrollment
60 (false)

8. Arms, Groups, and Interventions

Intervention Type
Drug
Intervention Name(s)
Gabapentin
Intervention Type
Drug
Intervention Name(s)
S-ketamine
Intervention Type
Drug
Intervention Name(s)
Lidocaine
Intervention Type
Drug
Intervention Name(s)
Droperidol
Primary Outcome Measure Information:
Title
1. postoperative abilities over time in PACU
Title
2. discharge time from PACU according to fixed criteria
Title
3. consumption of analgesics and antiemetics in the PACU
Secondary Outcome Measure Information:
Title
1. Degree of nursing requirements in the PACU
Title
2. General tolerability of the regimens

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Elective laparoscopic cholecystectomy Age above 18 years Written informed consent ASA class I-III Exclusion Criteria: Planned abdominal cholecystectomy Intraoperative conversion of laparoscopic to laparotomic cholecystectomy Allergy to part of the treatment regimens Previous reactions to opioids (nausea, cognition)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Kenneth Jensen, M.D.
Phone
+45 36 32 62 90
Email
kenneth.jensen@hh.hosp.dk
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kenneth Jensen, M.D.
Organizational Affiliation
Dept of Anaesthesia, Acute Pain Service, Hvidovre Hospital, Copenhagen, Denmark
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Claus Lund, dr.med.sci
Organizational Affiliation
Dept of Anaesthesia, Hvidovre Hospital, Copenhagen, Denmark
Official's Role
Study Chair
Facility Information:
Facility Name
Dept of Anaesthesia, Hvidovre Hospital
City
Copenhagen
State/Province
Hvidovre
ZIP/Postal Code
2650
Country
Denmark
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Kenneth Jensen, M.D.
Phone
+45 36 32 62 90
Email
kenneth.jensen@hh.hosp.dk
First Name & Middle Initial & Last Name & Degree
Kenneth Jensen, M.D.

12. IPD Sharing Statement

Links:
URL
http://www.postoppain.org
Description
URL looking into anaesthesia and surgery for cholecystectomy

Learn more about this trial

Optimal Multimodal Analgesia in Laparoscopic Cholecystectomy

We'll reach out to this number within 24 hrs